Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes

Diabetes Care

Volumn 34, Issue 5, 2011, Pages 1199-1204

  Saulnier, Pierre Jean ^a,b   Roussel, Ronan ^c,d,e   Halimi, Jean Michel ^a   Lebrec, Jeremie ^a   Dardari, Dured ^f   Maimaitiming, Sulyia ^c,d   Guilloteau, Gérard ^g   Prugnard, Xavier ^h   Marechaud, Richard ^b,h   Ragot, Stephanie ^a,b   Marre, Michel ^c,d,e   Hadjadj, Samy ^a,b,c,h  

^a Centre d'Investigation Clinique   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BICHAT HOSPITAL   (France)

^f CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC PEPTIDE RECEPTOR C;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE STRUCTURE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NPR3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 79956119040     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2057     Document Type: Article

References (25)

1. Newton-Cheh C, Larson MG, Vasan RS, et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 2009;41:348-353
2. Beretta-Piccoli C, Weidmann P. Body sodium-blood volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab 1982;7:36-47 (Pubitemid 12169924)
3. O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan DJ. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985;7:II43-II48
4. DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981;21:165-171
5. Matsukawa N, Grzesik WJ, Takahashi N, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 1999;96:7403-7408 (Pubitemid 29299674)
6. Sarzani R, Dessì-Fulgheri P, Salvi F, et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999;17:1301-1305 (Pubitemid 29509509)
7. Pitzalis MV, Sarzani R, Dessì-Fulgheri P, et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003;21:1491-1496 (Pubitemid 36994127)
8. Aoi N, Soma M, Nakayama T, et al. Variable number of tandem repeat of the 59-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004;27:711-716 (Pubitemid 40045509)
9. Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J; DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004;328:495
10. Hadjadj S, Fumeron F, Roussel R, et al.; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. Diabetes Care 2008;31:1847-1852
11. Roussel R, Bellili N, Hadjadj S, Péan F, Jeunemaitre X, Marre M. A novel variant in exon 8 of natriuretic peptide clearance receptor (NPRC) gene is associated with progression of nephropathy in type 1 diabetic patients. In Proceedings of the 40th Annual Meeting of the European Association for the Study of Diabetes, Munich, Germany, 2004 [Internet]. Available from http://87.234.226.93/easd-intranet/UpApplications/UpAppGlobal/AppFrameset.asp? rq-lLevel5648&rq-lAppId5217&rq-lGroupId543. Accessed 1 April 2011
12. Fox AA, Collard CD, Shernan SK, et al. Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. Anesthesiology 2009;110:738-747
13. Lanfear DE, Stolker JM, Marsh S, Rich MW, McLeod HL. Genetic variation in the B-type natriuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 2007;21:55-62 (Pubitemid 46594988)
14. Iemitsu M, Maeda S, Otsuki T, et al. Arterial stiffness, physical activity, and atrial natriuretic peptide gene polymorphism in older subjects. Hypertens Res 2008;31:767-774 (Pubitemid 351772868)
15. Trevisan R, Fioretto P, Semplicini A, et al. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 1990;39:289-298 (Pubitemid 20076211)
16. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999;138:211-219
17. Vedovato M, Lepore G, Coracina A, et al. Effect of sodium intake on blood pressure and albuminuria in type 2 diabetic patients: the role of insulin resistance. Diabetologia 2004;47:300-303
18. Jelić S, Šumarac-Dumanović M, Č aparević Z. Does salt sensitivity influence the magnitude of microalbuminuria in hypertensive type 2 diabetes patients (Abstract)? In Proceedings of the 21st Annual Meeting of the European Diabetic Nephropathy Study Group, Hannover, Germany, 2008. p. 57
19. Sanders PW. Dietary salt intake, salt sensitivity, and cardiovascular health. Hypertension 2009;53:442-445
20. Sun JZ, Chen SJ, Majid-Hasan E, Oparil S, Chen YF. Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP. Am J Physiol Renal Physiol 2002;282:F220-F227 (Pubitemid 34654552)
21. Murthy KS, Makhlouf GM. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J Biol Chem 1999;274:17587-17592
22. Murthy KS, Teng B, Jin J, Makhlouf GM. G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 1998;275:C1409-C1416
23. Zhou H, Murthy KS. Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am J Physiol Cell Physiol 2003;284:C1255-C1261 (Pubitemid 36457406)
24. Ardaillou N, Placier S, Striker L, Striker G, Ardaillou R. Mesangial cells from diabetic NOD mice constitutively express increased density of atrial natriuretic peptide C receptors. Kidney Int 1999;55:1293-1302 (Pubitemid 29157127)
25. Sun B, Williams JS, Svetkey LP, Kolatkar NS, Conlin PR. Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. Am J Clin Nutr 2010;92:444-449